Company Filing History:
Years Active: 2020
Title: Gloria Spagnoli: Innovator in HPV Immunogenicity
Introduction
Gloria Spagnoli is a prominent inventor based in Collecchio, Italy. She has made significant contributions to the field of immunology, particularly in the development of vaccines against human papillomavirus (HPV). Her work focuses on creating innovative solutions to combat HPV infections, which are known to lead to various health complications.
Latest Patents
Gloria Spagnoli holds a patent for an immunogenic polypeptide that comprises a multitude of HPV L2 N-terminal peptides. This invention specifically targets amino acids 20 to 50 of the L2 polypeptide of HPV16. The polypeptide is designed for use in medicine and vaccination against HPV infection. Additionally, her patent includes a polynucleotide encoding the immunogenic polypeptide and a host cell that comprises the same. The invention also encompasses kits, methods, and uses related to the immunogenic polypeptide.
Career Highlights
Gloria Spagnoli is associated with the Deutsches Krebsforschungszentrum, where she has been instrumental in advancing research on HPV. Her dedication to scientific innovation has led to the development of groundbreaking technologies that enhance our understanding of immunogenic responses.
Collaborations
Throughout her career, Gloria has collaborated with notable colleagues, including Angelo Bolchi and Martin Müller. These partnerships have fostered a collaborative environment that promotes the exchange of ideas and expertise in the field of immunology.
Conclusion
Gloria Spagnoli's contributions to HPV immunogenicity represent a significant advancement in medical science. Her innovative work continues to pave the way for effective vaccination strategies against HPV infections.